SR

Santosh Rajendra Damkondwar

Active Director Designated Partner DIN 10673694
DIN 10673694 First appointment Jun 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Santosh Rajendra Damkondwar

Data last updated:

Santosh Rajendra Damkondwar is a Designated Partner at Nanded A. V. S. Pharma Llp (since 2024).

DIN 10673694
Primary Designation Designated Partner
First Appointment 19 Jun 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner19 Jun 20242024Active

Board colleagues of Santosh Rajendra Damkondwar

Directorship timeline

Open interactive timeline →
Nanded A. V. S. Pharma Llp
Premium access

Shareholding and investment profile for Santosh Rajendra Damkondwar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Santosh Rajendra Damkondwar

Santosh Rajendra Damkondwar currently holds 1 directorship: Nanded A. V. S. Pharma Llp (Designated Partner, since 19 Jun 2024).

Santosh Rajendra Damkondwar was first appointed on 19 Jun 2024 as Designated Partner at Nanded A. V. S. Pharma Llp.

The current boards of Santosh Rajendra Damkondwar's companies include Balaji Sheshrao Honrao (Nanded A. V. S. Pharma Llp), Gurdeepsingh Kewalsingh Chiragiya (Nanded A. V. S. Pharma Llp), Narendra Prabhakar Kulkarni (Nanded A. V. S. Pharma Llp), Shantanu Sudhakarrao Kodgire (Nanded A. V. S. Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available